Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.
Jay S SkylerGeorge L BakrisEzio BonifacioTamara DarsowRobert H EckelLeif C GroopPer-Henrik GroopYehuda HandelsmanRichard A InselChantal MathieuAllison T McElvaineJerry P PalmerAlberto PuglieseDesmond A SchatzJay M SosenkoJohn P H WildingRobert E RatnerPublished in: Diabetes (2016)
The American Diabetes Association, JDRF, the European Association for the Study of Diabetes, and the American Association of Clinical Endocrinologists convened a research symposium, "The Differentiation of Diabetes by Pathophysiology, Natural History and Prognosis" on 10-12 October 2015. International experts in genetics, immunology, metabolism, endocrinology, and systems biology discussed genetic and environmental determinants of type 1 and type 2 diabetes risk and progression, as well as complications. The participants debated how to determine appropriate therapeutic approaches based on disease pathophysiology and stage and defined remaining research gaps hindering a personalized medical approach for diabetes to drive the field to address these gaps. The authors recommend a structure for data stratification to define the phenotypes and genotypes of subtypes of diabetes that will facilitate individualized treatment.